Page last updated: 2024-10-27

fluoxetine and Atrial Septal Defect

fluoxetine has been researched along with Atrial Septal Defect in 2 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Christodoulos, IN1
Chyou, TY1
Nishtala, PS1
Grover, S1
Agarwal, M1
Hegde, A1
Malhotra, N1
Somaiya, M1
Ghormode, D1

Other Studies

2 other studies available for fluoxetine and Atrial Septal Defect

ArticleYear
Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database.
    European journal of clinical pharmacology, 2020, Volume: 76, Issue:12

    Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Second-Generation; Anxie

2020
Electroconvulsive therapy in the presence of atrial septal defect: a case report.
    The journal of ECT, 2012, Volume: 28, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Combined Modality T

2012